The Central Nervous System Cns

Corium ADLARITY PressRelease

Second CNS product approval for Corium in 12 months . Boston, MA, March 14, 2022 – Corium, Inc., a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, announced today the U.S. Food and Drug Administration

  System, Central, Nervous, Central nervous system